{"id":62655,"date":"2022-04-13T10:49:28","date_gmt":"2022-04-13T08:49:28","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=62655"},"modified":"2023-09-21T09:18:03","modified_gmt":"2023-09-21T09:18:03","slug":"nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/","title":{"rendered":"Nueva formaci\u00f3n sobre las indicaciones y los tratamientos de las hipoglucemias graves en el COFB"},"content":{"rendered":"<p>El <strong>pasado 7 de abril<\/strong> tuvo lugar en <strong>Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)<\/strong> la <strong>formaci\u00f3n<\/strong> <strong>\u201cHipoglucemias graves, \u00bfqu\u00e9 podemos hacer? Indicaciones y tratamientos\u201d<\/strong>. Patrocinada por <a href=\"https:\/\/www.lilly.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Lilly<\/a> y organizada conjuntamente con la <a href=\"http:\/\/www.scfarmclin.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">Sociedad Catalana de Farmacia Cl\u00ednica<\/a>, ten\u00eda por <strong>objetivos<\/strong> que los asistentes se pusieran al d\u00eda en cuanto a las <strong>gu\u00edas<\/strong> y las <strong>recomendaciones<\/strong> para tratar las <strong>hipoglucemias<\/strong> y las <strong>hipoglucemias graves<\/strong>, ampliaran <strong>conocimientos<\/strong> sobre los <strong>tratamientos disponibles<\/strong> y adquirieran <strong>habilidades de actuaci\u00f3n farmac\u00e9utica<\/strong> en el <strong>tratamiento del paciente<\/strong>. <\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/04\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513.jpg\" alt=\"El passat 7 d'abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 &quot;Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments&quot;. \" class=\"wp-image-62908\" title=\"El pasado 7 de abril tuvo lugar en el Colegio de Farmac\u00e9uticos de Barcelona (COFB) la formaci\u00f3n &quot;Hipoglucemias graves, \u00bfqu\u00e9 podemos hacer? Indicaciones y tratamientos&quot;.\"\/><figcaption class=\"wp-element-caption\"> El pasado 7 de abril tuvo lugar en el Colegio de Farmac\u00e9uticos de Barcelona (COFB) la formaci\u00f3n \u201cHipoglucemias graves, \u00bfqu\u00e9 podemos hacer? Indicaciones y tratamientos\u201d. <\/figcaption><\/figure>\n\n\n\n<p>La <strong>formaci\u00f3n<\/strong> se dirig\u00eda a <strong>farmac\u00e9uticos hospitalarios<\/strong>, de<strong>Atenci\u00f3n Primaria<\/strong> y <strong>comunitarios<\/strong>. Las ponentes fueron la <strong>Dra. Marga Gim\u00e9nez<\/strong>, jefe de la Unidad de Diabetes, del Departamento de Endocrinolog\u00eda del Hospital Cl\u00ednic y <strong>Cristina Morales<\/strong>, farmac\u00e9utica de Atenci\u00f3n Primaria de la Unidad de Farmacia del SAP Vall\u00e8s Oriental.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Aspectos cl\u00ednicos y consecuencias<\/strong> <strong>de las hipoglucemias<\/strong><\/h2>\n\n\n\n<p>Tal y como expuso la Dra. Marga Gim\u00e9nez, \u201cen <strong>diabetes<\/strong>, en los \u00faltimos a\u00f1os, ha cambiado la definici\u00f3n de<strong>hipoglucemia<\/strong>. De hecho, entendemos como <strong>hipoglucemia <\/strong>cualquier episodio en el que el paciente presenta una <strong>glucemia inferior a 70 mg\/dl<\/strong>. En la \u00faltima \u00e9poca, los <strong>episodios de hipoglucemia<\/strong> se han dividido en <strong>dos niveles<\/strong>. Entendemos como <strong>nivel 1 <\/strong>los valores de hipoglucemia entre <strong>70 y 54 mg\/dl<\/strong> y como <strong>nivel 2<\/strong> se consideran todos los episodios que tienen asociado un valor de glucosa <strong>por debajo de 54<\/strong>. En este segundo nivel, es cuando el riesgo de <strong>neuroglucopenia<\/strong> y <strong>eventos agudos<\/strong> y el <strong>riesgo de hipoglucemia grave<\/strong> se incrementa\u201d. <\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/04\/1649334856483-1024x576.jpg\" alt=\"La Dra. Marga Gim\u00e9nez, cap de la Unitat de Diabetis, del Departament d'Endocrinologia de l'Hospital Cl\u00ednic.\" class=\"wp-image-62914\" title=\"La Dra. Marga Gim\u00e9nez, jefa de la Unidad de Diabetes, del Departamento de Endocrinolog\u00eda del Hospital Cl\u00ednic.\"\/><figcaption class=\"wp-element-caption\">La Dra. Marga Gim\u00e9nez, jefa de la Unidad de Diabetes, del Departamento de Endocrinolog\u00eda del Hospital Cl\u00ednic.<\/figcaption><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Sintomatolog\u00eda<\/strong><\/h3>\n\n\n\n<p>En cuanto a la <strong>sintomatolog\u00eda<\/strong> asociada a los <strong>episodios de hipoglucemia<\/strong>, la <strong>Dra. Gim\u00e9nez<\/strong> diferenci\u00f3, por un lado, \u201clos s\u00edntomas m\u00e1s <strong>adren\u00e9rgicos<\/strong> y que suelen presentarse al<strong>inicio de la enfermedad<\/strong>, durante los primeros a\u00f1os. Suelen ser <strong>sintomatolog\u00edas vinculadas al estr\u00e9s<\/strong>, que hacen que la persona se sienta mal y tenga <strong>ganas de comer<\/strong> (ejemplo: sudor, hambre, encontrarse mal, palpitaciones, sensaci\u00f3n que de tener que buscar algo para comer y resolver esa situaci\u00f3n). Esto es lo que acaba constituyendo lo que conocemos como la <strong>tr\u00edada<\/strong> de la <strong>detecci\u00f3n<\/strong> y el <strong>tratamiento<\/strong> de la <strong>hipoglucemia<\/strong>. En otras palabras: determinar el valor de glucosa, tener s\u00edntomas compatibles, comida y desaparezcan los s\u00edntomas\u201d. <\/p>\n\n\n\n<p>Por otra parte, la doctora a\u00f1adi\u00f3 que \u201ccuando esto sucede durante muchas veces, a lo largo de muchos a\u00f1os, o cuando existe <strong>determinados f\u00e1rmacos<\/strong> o <strong>situaciones concomitantes<\/strong>, con el tiempo se van perdiendo estos <strong>s\u00edntomas adren\u00e9rgicos<\/strong> y aparecen unos <strong>otros s\u00edntomas<\/strong> que son <strong>neuroglucop\u00e9nicos<\/strong>, que ya no son tan f\u00e1ciles de detectar (la persona ya no tiene la necesidad de comer algo dulce) y quiz\u00e1 el<strong>\u00fanica sintomatolog\u00eda <\/strong>es que ya no<strong> es capaz de concentrarse en el trabajo<\/strong> que est\u00e1 haciendo o que hace alguna <strong>cosa rutinaria<\/strong> muchas veces seguidas\u201d. <\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/04\/COFB_Hipoglucemies-greus_070422_3.jpg\" alt=\"Cristina Morales, farmac\u00e8utica d'Atenci\u00f3 Prim\u00e0ria de la Unitat de Farm\u00e0cia del SAP Vall\u00e8s Oriental i la Dra. Marga Gim\u00e9nez, cap de la Unitat de Diabetis, del Departament d'Endocrinologia de l'Hospital Cl\u00ednic.\" class=\"wp-image-63011\" title=\"Cristina Morales, farmac\u00e9utica de Atenci\u00f3n Primaria de la Unidad de Farmacia del SAP Vall\u00e8s Oriental y la Dra. Marga Gim\u00e9nez, jefa de la Unidad de Diabetes, del Departamento de Endocrinolog\u00eda del Hospital Cl\u00ednic.\"\/><figcaption class=\"wp-element-caption\">Cristina Morales, farmac\u00e9utica de Atenci\u00f3n Primaria de la Unidad de Farmacia del SAP Vall\u00e8s Oriental y la Dra. Marga Gim\u00e9nez, jefa de la Unidad de Diabetes, del Departamento de Endocrinolog\u00eda del Hospital Cl\u00ednic.<\/figcaption><\/figure>\n\n\n\n<p>Sea como fuere, seg\u00fan expuso la doctora, \u201cindependientemente del <strong>valor de glucosa<\/strong> que tengas o independientemente de los <strong>s\u00edntomas que tengas<\/strong>, se considerar\u00e1 grave cualquiera <strong>hipoglucemia<\/strong> cuando <strong>vaya asociada<\/strong> a uno <strong>estado de neuroglucopenia<\/strong> suficiente como para que el paciente no sea capaz de <strong>resolver aquella situaci\u00f3n<\/strong>&#8220;. <\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>El profesional farmac\u00e9utico y la educaci\u00f3n diabetol\u00f3gica<\/strong><\/h2>\n\n\n\n<p>Por su parte, <strong>Cristina Morales<\/strong>, farmac\u00e9utica de atenci\u00f3n primaria de la <strong>Unidad de Farmacia SAP Vall\u00e8s Oriental<\/strong>, comenz\u00f3 su <strong>intervenci\u00f3n<\/strong> refiri\u00e9ndose al<strong>objetivo del tratamiento <\/strong>de la <strong>hipoglucemia grave<\/strong>, que consiste en <strong>normalizar la concentraci\u00f3n de glucosa plasm\u00e1tica<\/strong>. A continuaci\u00f3n, hizo referencia a los tipos de <strong>glucag\u00f3n<\/strong>, a los<strong> mecanismos de acci\u00f3n <\/strong>de \u00e9ste ya su <strong>indicaci\u00f3n<\/strong> y <strong>posolog\u00eda<\/strong>.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/04\/COFB_Hipoglucemies-greus_070422_2-1024x585.jpg\" alt=\"Cristina Morales, farmac\u00e8utica d'Atenci\u00f3 Prim\u00e0ria de la Unitat de Farm\u00e0cia SAP Vall\u00e8s Oriental. \" class=\"wp-image-62988\" title=\"Cristina Morales, farmac\u00e9utica de atenci\u00f3n primaria de la Unidad de Farmacia SAP Vall\u00e8s Oriental.\"\/><figcaption class=\"wp-element-caption\">Cristina Morales, farmac\u00e9utica de Atenci\u00f3n Primaria de la Unidad de Farmacia SAP Vall\u00e8s Oriental.<\/figcaption><\/figure>\n\n\n\n<p>As\u00ed como en las <strong>situaciones especiales<\/strong> y las <strong>contraindicaciones<\/strong> (<strong>hipersensibilidad principio activo<\/strong> y\/o <strong>excipientes<\/strong>, <strong>feocromocitoma<\/strong> ii<strong>nsulinoma<\/strong>). Tambi\u00e9n record\u00f3 que el <strong>glucag\u00f3n<\/strong> no es efectivo en pacientes con <strong>gluc\u00f3geno hep\u00e1tico agotado<\/strong>. Por tanto, no es efectivo en <strong>ayunas prolongadas<\/strong>, <strong>insuficiencia adrenal<\/strong>, <strong>hipoglucemia cr\u00f3nica<\/strong> y <strong>hipoglucemia inducida por alcohol<\/strong>.<\/p>\n\n\n<div class=\"destacat-blog\">\n\n\n<h3 class=\"wp-block-heading\"><strong>Hipoglucemia<\/strong><\/h3>\n\n\n\n<p>La <strong>hipoglucemia<\/strong> se define como <strong>cualquier episodio<\/strong>, con o sin s\u00edntomas, en que los <strong>niveles plasm\u00e1ticos de glucosa<\/strong> se sit\u00faan por debajo de <strong>70 mg\/dl<\/strong> o <strong>3.9 mmol\/L<\/strong>. Se calcula que los <strong>pacientes con DM1<\/strong> pueden tener una <strong>media de dos episodios de hipoglucemia sintom\u00e1tica\/semana<\/strong> y <strong>uno grave al a\u00f1o<\/strong> mientras que los <strong>pacientes con DM2<\/strong> el<strong>estimaci\u00f3n de hipoglucemia grave <\/strong>es de <strong>12 episodios\/100 pacientes\/a\u00f1o<\/strong>. <\/p>\n\n\n\n<p>Estos <strong>episodios<\/strong> pueden ser causados por <strong>dosis inadecuadas de antidiab\u00e9ticos <\/strong>sumadas a una <strong>alimentaci\u00f3n insuficiente <\/strong>y <strong>falta de ejercicio f\u00edsico<\/strong>.<\/p> <\/div>\n\n\n\n<p>En la parte final de su<strong> intervenci\u00f3n<\/strong>, Morales se refiri\u00f3 a los <strong>puntos clave<\/strong> de <strong>la educaci\u00f3n diabetol\u00f3gica<\/strong>: s\u00edntomas de alerta, causas, autotratamiento a domicilio (y en otros entornos como el escolar), prevenci\u00f3n de las hipoglucemias, registro de la hipoglucemia y causa, e informaci\u00f3n al paciente y familiares centrada en la utilizaci\u00f3n y conservaci\u00f3n del glucag\u00f3n. <\/p>\n\n\n\n<p><\/p>\n\n\n\n<p class=\"has-text-align-right\"><strong>Actividad organizada conjuntamente con:<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image alignright size-full is-resized\"><a href=\"http:\/\/www.scfarmclin.org\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/04\/Societat-Catalana-de-Farmacia-Clinica.png\" alt=\"\" class=\"wp-image-62730\" style=\"width:114px;height:74px\" width=\"114\" height=\"74\"\/><\/a><\/figure>\n\n\n\n<p class=\"has-text-align-right\"><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p class=\"has-text-align-right\"><strong>Con el patrocinio de:<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image alignright size-full is-resized\"><a href=\"https:\/\/www.lilly.com\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/04\/Lilly.png\" alt=\"\" class=\"wp-image-62726\" style=\"width:103px;height:61px\" width=\"103\" height=\"61\"\/><\/a><\/figure>","protected":false},"excerpt":{"rendered":"<p>El pasado 7 de abril tuvo lugar en el Colegio de Farmac\u00e9uticos de Barcelona (COFB) la formaci\u00f3n \u201cHipoglucemias graves, \u00bfqu\u00e9 podemos hacer? Indicaciones y tratamientos\u201d. Patrocinada por Lilly y organizada conjuntamente con la Sociedad Catalana de Farmacia Cl\u00ednica, ten\u00eda por objetivos que los asistentes se pusieran al d\u00eda por lo que [\u2026]<\/p>","protected":false},"author":1,"featured_media":67930,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[36,16,653,64,654,18,19,197,53,68,69,25,70,300,655,656,657,262,637,658],"class_list":["post-62655","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-alimentacio","tag-alimentacio-i-nutricio","tag-antidiabetics","tag-atencio-farmaceutica","tag-campanya-atencio-diabetis","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-diabetis","tag-farmaceutics","tag-farmacia","tag-farmacia-comunitaria","tag-farmacies","tag-formacio","tag-formacio-continuada","tag-hipoglucemies","tag-hipoglucemies-greus","tag-nivells-plasmatics","tag-oficines-de-farmacia","tag-programa-de-formacio-continuada","tag-risc-de-patir-diabetis"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 7 d&#039;abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 &quot;Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments&quot;.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 7 d&#039;abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 &quot;Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments&quot;.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-13T08:49:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-21T09:18:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"513\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB\",\"datePublished\":\"2022-04-13T08:49:28+00:00\",\"dateModified\":\"2023-09-21T09:18:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/\"},\"wordCount\":977,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg\",\"keywords\":[\"alimentaci\u00f3\",\"Alimentaci\u00f3 i nutrici\u00f3\",\"antidiab\u00e8tics\",\"Atenci\u00f3 farmac\u00e8utica\",\"campanya atenci\u00f3 diabetis\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"diabetis\",\"farmac\u00e8utics\",\"Farm\u00e0cia\",\"farm\u00e0cia comunit\u00e0ria\",\"farm\u00e0cies\",\"Formaci\u00f3\",\"formaci\u00f3 continuada\",\"hipogluc\u00e8mies\",\"hipogluc\u00e8mies greus\",\"nivells plasm\u00e0tics\",\"oficines de farm\u00e0cia\",\"programa de formaci\u00f3 continuada\",\"risc de patir diabetis\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/\",\"name\":\"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg\",\"datePublished\":\"2022-04-13T08:49:28+00:00\",\"dateModified\":\"2023-09-21T09:18:03+00:00\",\"description\":\"El passat 7 d'abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 \\\"Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments\\\".\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg\",\"width\":1024,\"height\":513},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 7 d'abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 \"Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments\".","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/","og_locale":"es_ES","og_type":"article","og_title":"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 7 d'abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 \"Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments\".","og_url":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2022-04-13T08:49:28+00:00","article_modified_time":"2023-09-21T09:18:03+00:00","og_image":[{"width":1024,"height":513,"url":"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg","type":"image\/jpeg"}],"author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB","datePublished":"2022-04-13T08:49:28+00:00","dateModified":"2023-09-21T09:18:03+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/"},"wordCount":977,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg","keywords":["alimentaci\u00f3","Alimentaci\u00f3 i nutrici\u00f3","antidiab\u00e8tics","Atenci\u00f3 farmac\u00e8utica","campanya atenci\u00f3 diabetis","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","diabetis","farmac\u00e8utics","Farm\u00e0cia","farm\u00e0cia comunit\u00e0ria","farm\u00e0cies","Formaci\u00f3","formaci\u00f3 continuada","hipogluc\u00e8mies","hipogluc\u00e8mies greus","nivells plasm\u00e0tics","oficines de farm\u00e0cia","programa de formaci\u00f3 continuada","risc de patir diabetis"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/","url":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/","name":"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg","datePublished":"2022-04-13T08:49:28+00:00","dateModified":"2023-09-21T09:18:03+00:00","description":"El passat 7 d'abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 \"Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments\".","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg","width":1024,"height":513},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg",1024,513,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1-300x150.jpg",300,150,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1-768x385.jpg",768,385,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg",1024,513,false],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg",1024,513,false],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg",1024,513,false],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg",18,9,false]},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 7 d&#8217;abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 &#8220;Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments&#8221;. Patrocinada per Lilly i organitzada conjuntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica, tenia per objectius que els assistents es posessin al dia pel que [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/62655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=62655"}],"version-history":[{"count":2,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/62655\/revisions"}],"predecessor-version":[{"id":68739,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/62655\/revisions\/68739"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media\/67930"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=62655"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=62655"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=62655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}